Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participants treated with vimseltinib for TGCT. T...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Deciphera Pharmaceuticals, LLC
NCT04635111 · Hepatotoxicity, Tenosynovial Giant Cell Tumor
NCT03069469 · Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, and more
NCT04488822 · Tenosynovial Giant Cell Tumor
NCT05349643 · Pigmented Villonodular Synovitis, TGCT, and more
NCT04731675 · Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis (PVNS)
Synexus Clinical Research, US INC
Wilmington, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions